A therapy to boost the production of regulatory T-cells prevented inhibitor formation in a mouse model of hemophilia A, per a ...

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced the voting ...

Schrodinger delivers strong Q1 results, driven by software growth and evolving FDA regulations. Read more to see why SDGR ...

A new AI model developed by researchers at the Eric and Wendy Schmidt Center at the Broad Institute and ETH Zurich's ...

A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of ...

Researchers at the Center for Genomic Regulation (CRG) created an AI tool which dreams up DNA regulatory ... T, C, G) are needed for the gene expression patterns required in specific types of cells.

B-cell lymphoma 6; BLIMP-1, B Lymphocyte-Induced Maturation Protein 1; RORγt, Retinoic Acid Receptor-Related Orphan Receptor Gamma t; Treg, Regulatory T Cell; TGF-β, Transforming Growth Factor Beta; ...

A Phase I clinical trial, whose results have been published in the prestigious journal Blood, reveals that this new CAR-T30 therapy promotes the expansion of memory T cells, leading to long ...

NEW YORK, NY, USA I April 28, 2025 I IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies for cancer and autoimmune diseases, ...

ABP-102/CT-P72, a tetravalent bispecific HER2 x CD3 T-cell engager co-developed with ... Abpro’s ability to obtain and maintain regulatory approval of product candidates; Abpro’s ability ...

"The government is making it clear that breaking rules won’t just cost companies in fines, but also in higher taxes. This change stops companies from saving tax on money spent to settle cases where ...